Pay in 4 interest-free payments of $18.75 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
S3I-201 (NSC-74859) preferentially inhibits Stat3 DNA-binding activity over that of Stat1 (IC50 values
Abstract DDT02-01: GDC-0068: A novel
and effecting cellular metabolism
CAY10603 has potent antiproliferative activity against pancreatic cancer cell lines with IC50 of <1 μM
4-Hydroxytamoxifen
SAG - Hedgehog Agonist. CAS# 912545-86-9 size:2 mg solid S3I-201 (NSC-74859) preferentially inhibits Stat3SAG, CAS NO. 912545 86 9, is a potent, selective, and cell permeable small molecule agonist of the Hedgehog pathway. It modulates the coupling of Smo with its downstream effector by interacting with the Smo heptahelical domain (KD = 59 nM). SAG induces Hedgehog pathway activation with an EC50 of ~3 nM in NIH 3T3 derived Shh LIGHT2 cells and counteracts Cyclopamine KAAD inhibition of Smo. It was reported that SAG acts as an activator at low
US$ 29.21
US$ 27.63
US$ 24.47
US$ 21.30